Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 10Venous Thromboembolism 7Venous Thrombosis 3Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 3Upper Extremity Deep Vein Thrombosis 2Thrombosis 1Recurrence 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Myeloproliferative Disorders 1Lung Neoplasms 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Tranexamic Acid 6Sodium Chloride 2Ringer's Lactate 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Uterine Artery Embolization 1Tourniquets 1Sutures 1Surgicel 1Saline Solution 1Rivaroxaban 1Ringer's Solution 1Pancreaticoduodenectomy 1Mannitol 1Lenalidomide 1Ibuprofen 1Goserelin 1Gonadotropin-Releasing Hormone 1Furosemide 1FloSeal Matrix 1Esomeprazole 1Data Collection 1Dalteparin 1Crystalloid Solutions 1Colloids 1Blood Transfusion 1Bevacizumab 1Aspirin 1Arginine Vasopressin 1Arginine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemorrhage × Rivaroxaban × Clear all
NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Seoul National University Hospital

Phase 4 Completed
127 enrolled

Hemorrhage, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡